
Imvax
Developer of patient-specific vaccines and immunotherapy strategies designed for the treatment of malignant gliomas and other cancers with unmet medical needs. The company's product is an autologous t...
Valuation
$0
Share Price
N/A
Total Raised
$237.9M
Last Round
N/A